Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $608M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 3,006,980 | $95.95M | 15.8% | $47.09 | -36.1% | COM | 03753U106 |
| AVBP | ARRIVENT BIOPHARMA INC | 2,059,387 | $54.86M | 9.0% | $20.73 | +38.5% | COM | 04272N102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,110,167 | $46M | 7.6% | $20.37 | +26.2% | COM | 252828108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,993,052 | $33.38M | 5.5% | $7.34 | — | SPONSORED ADS | 152309100 |
| — | VERONA PHARMA PLC | 571,264 | $26.53M | 4.4% | $17.59 | — | SPONSORED ADS | 925050106 |
| NUVB | NUVATION BIO INC | 9,202,907 | $24.48M | 4.0% | $2.99 | -14.0% | COM CL A | 67080N101 |
| INSM | INSMED INC | 332,000 | $22.92M | 3.8% | $21.76 | +231.0% | COM PAR | 457669307 |
| COGT | COGENT BIOSCIENCES INC | 2,763,000 | $21.55M | 3.5% | $9.86 | +1.1% | COM | 19240Q201 |
| SRRK | SCHOLAR ROCK HLDG CORP | 488,000 | $21.09M | 3.5% | $32.56 | 0.0% | COM | 80706P103 |
| — | MIND MEDICINE MINDMED INC | 3,018,000 | $21.01M | 3.5% | $8.34 | — | COM NEW | 60255C885 |
| OCUL | OCULAR THERAPEUTIX INC | 2,425,000 | $20.71M | 3.4% | $7.10 | +37.5% | COM | 67576A100 |
| TSHA | TAYSHA GENE THERAPIES INC | 10,450,000 | $18.08M | 3.0% | $2.20 | -5.7% | COM SHS | 877619106 |
| INSM | INSMED INC | 250,000 | $17.26M | 2.8% | $21.76 | +231.0% | Call | 457669307 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 870,000 | $16.68M | 2.7% | $22.43 | -3.1% | COM | 92790C104 |
| GOSS | GOSSAMER BIO INC | 18,350,000 | $16.6M | 2.7% | $1.89 | -54.8% | COM | 38341P102 |
| DYN | DYNE THERAPEUTICS INC | 668,000 | $15.74M | 2.6% | $24.32 | +21.6% | COM | 26818M108 |
| PHVS | PHARVARIS N V | 778,000 | $14.91M | 2.5% | $18.74 | +9.8% | COM | N69605108 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 1,115,000 | $13.16M | 2.2% | $40.87 | -59.0% | COM NEW | 21833P301 |
| — | MERUS N V | 308,000 | $12.95M | 2.1% | $42.05 | — | COM | N5749R100 |
| ERAS | ERASCA INC | 5,136,795 | $12.89M | 2.1% | $2.74 | 0.0% | COM | 29479A108 |
| BBIO | BRIDGEBIO PHARMA INC | 441,600 | $12.12M | 2.0% | $30.51 | -15.3% | COM | 10806X102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 904,000 | $11.95M | 2.0% | $17.11 | 0.0% | COM | 87164F105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,370,000 | $11.6M | 1.9% | $10.36 | 0.0% | COM | 483497103 |
| — | UNICYCIVE THERAPEUTICS INC | 10,000,000 | $7.942M | 1.3% | $0.46 | — | COM | 90466Y103 |
| — | REGULUS THERAPEUTICS INC | 4,848,802 | $7.661M | 1.3% | $1.76 | — | COM | 75915K309 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 2,304,752 | $7.352M | 1.2% | $12.05 | -32.2% | COM NEW | 46489V302 |
| NGNE | NEUROGENE INC | 303,000 | $6.927M | 1.1% | $37.29 | -0.2% | COM | 64135M105 |
| — | ALLOVIR INC | 11,215,000 | $4.71M | 0.8% | $0.42 | — | COM | 019818202 |
| ATYR | ATYR PHARMA INC | 900,000 | $3.258M | 0.5% | $3.03 | 0.0% | COM NEW | 002120202 |
| BBOT | HELIX ACQUISITION CORP II | 250,000 | $2.625M | 0.4% | $10.35 | +1.5% | CL A ORD SHS | G4444H101 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 152,000 | $2.546M | 0.4% | $7.34 | — | Put | 152309100 |
| — | MERSANA THERAPEUTICS INC | 992,000 | $1.419M | 0.2% | $4.48 | — | COM | 59045L106 |
| — | NUVATION BIO INC | 312,336 | $831K | 0.1% | $2.29 | — | *W EXP 02/10/202 | 67080N119 |